MMMMMMMMMMMMMMMMmmmmmmmm
I think potency assay data has proven sufficient but there is still outstanding issues to resolve. Why weren't they resolved as per CRL advice?
"seeking to address all remaining product characterization issues" - no slam dunk here as yet
Still - beats a no
Reg
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-31
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
-0.210(11.8%) |
Mkt cap ! $1.792B | |||
| Open | High | Low | Value | Volume |
| $1.72 | $1.74 | $1.52 | $15.63M | 9.716M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5127 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 39613 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |